1887
Volume 2024, Issue 2
  • E-ISSN: 3008-0738

ملخص

Epistaxis attacks in childhood are an important reason for pediatric emergency visits, most of which are minor and infrequent. However, recurrent epistaxis can be a sign of an underlying bleeding disorder such as von Willebrand disease. This case report highlights controversies and obstacles that may arise during the diagnostic process, hindering a clear confirmation.

An eight-year-old boy, who had a history of recurrent epistaxis and easy bruising since infancy, was presented to the Pediatric Emergency Department of Al Khor Hospital for a repeat episode of nosebleed. Local examination showed dilated capillaries in addition to nasal bleeding signs. Family history revealed similar past complaints in both his brother and his father. Previous epistaxis attacks were mostly left-sided. Blood workups were not diagnostic. Later, repeated blood tests led by high clinical suspicion resulted in the diagnosis of von Willebrand disease. The new diagnosis had a direct effect on the patient’s bleeding management. Nose bleeds peaked in frequency and severity over the next two years and decreased remarkably thereafter, the same pattern as before in the father and older brother.

The heterogeneous nature of von Willebrand disease, overlapping with the healthy population, creates a diagnostic dilemma. Therefore, balanced diagnostic approach is crucial. Bleeding history and family history provide invaluable clues but are not definitive. The blood workups may struggle with the variations in function and fluctuating levels of the von Willebrand factor molecule. Although genetic testing is helpful in some cases, it has its limitations.

The diagnosis of von Willebrand’s disease generally follows the traditional approach. It begins with a detailed bleeding history combined with a focused family history that pinpoints potential cases, followed by blood testing. However, interpretation of blood workups can be challenging due to the patient-to-patient and within-patient variability of the disease, the wide panel of investigations, and the different cutoff levels in different guidelines. Despite all this, testing is irreplaceable. Management of bleeding should begin immediately and should not be affected by inconclusive blood workups.

Loading

جارٍ تحميل قياسات المقالة...

/content/journals/10.5339/qjph.2024.13
٢٠٢٤-٠٩-٢٤
٢٠٢٤-١٠-١٦
Loading full text...

Full text loading...

/deliver/fulltext/qjph/2024/2/qjph.2024.13.html?itemId=/content/journals/10.5339/qjph.2024.13&mimeType=html&fmt=ahah

References

  1. Yan T, Goldman RD. Recurrent epistaxis in children. Canadian Family Physician. 2021; 67:(6):427–429. https://doi.org/10.46747/cfp.6706427. PMID: 34127465; PMCID: PMC8202740.
    [Google الباحث العلمي]
  2. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand’s disease. Blood. 1987; 69:(2):454–459. PMID: 3492222.
    [Google الباحث العلمي]
  3. Sandoval C, Dong S, Visintainer P, Fevzi Ozkaynak M, Jayabose S. Clinical and laboratory features of 178 children with recurrent epistaxis. Journal of Pediatric Hematology/Oncology. 2002; 24:(1):47–49. https://doi.org/10.1097/00043426-200201000-00013. PMID: 11902740.
    [Google الباحث العلمي]
  4. Stokhuijzen E, Segbefia CI, Biss TT, Clark DS, James PD, Riddel J, et al. Severity and features of epistaxis in children with a mucocutaneous bleeding disorder. The Journal of Pediatrics. 2018;193:183–189.e2. https://doi.org/10.1016/j.jpeds.2017.09.082. Epub 2017 Dec 1. PMID: 29198540.
    [Google الباحث العلمي]
  5. Kiley V, Stuart JJ, Johnson CA. Coagulation studies in children with isolated recurrent epistaxis. The Journal of Pediatrics. 1982; 100:(4):579–581. https://doi.org/10.1016/s0022-3476(82)80757-9. PMID: 7062204.
    [Google الباحث العلمي]
  6. Du P, Bergamasco A, Moride Y, Truong Berthoz F, Özen G, Tzivelekis S. Von Willebrand disease epidemiology, burden of illness and management: A systematic review. Journal of Blood Medicine. 2023;14:189–208. https://doi.org/10.2147/JBM.S389241. PMID: 36891166; PMCID: PMC9987238.
    [Google الباحث العلمي]
  7. Evan Sadler, J . Low von Willebrand factor: Sometimes a risk factor and sometimes a disease. Hematology. American Society of Hematology. Education Program. 2009; 2009:(1):106–112. https://doi.org/10.1182/asheducation-2009.1.106 .
    [Google الباحث العلمي]
  8. Lavin M, Aguila S, Schneppenheim S, Dalton N, Jones KL, O’Sullivan JM, et al. Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels. Blood. 2017; 130:(21):2344–2353.
    [Google الباحث العلمي]
  9. Favaloro EJ. Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies. Research and Practice in Thrombosis and Haemostasis. 2020; 4:(6):952–957. https://doi.org/10.1002/rth2.12392; .
    [Google الباحث العلمي]
  10. Federici AB. Clinical diagnosis of von Willebrand disease. Haemophilia: The Official Journal of the World Federation of Hemophilia. 2004; 10:(Suppl 4):169–176. https://doi.org/10.1111/j.1365-2516.2004.00991.x .
    [Google الباحث العلمي]
  11. Bowman M, Riddel J, Rand ML, Tosetto A, Silva M, James PD. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. Journal of Thrombosis and Hemostasis. 2009; 7:(8):1418–1421. https://doi.org/10.1111/j.1538-7836.2009.03499.x .
    [Google الباحث العلمي]
  12. Elbatarny M, Mollah S, Grabell J, Bae S, Deforest M, Tuttle A, et al. Normal range of bleeding scores for the ISTH-BAT: Adult and pediatric data from the merging project. Hemophilia: The Official Journal of the World Federation of Hemophilia. 2014; 20:(6):831–835. https://doi.org/10.1111/hae.12503 .
    [Google الباحث العلمي]
  13. Shen M-C, Chen M, Ma G-C, Chang S-P, Lin C-Y, Lin B-D, et al. De novo mutation and somatic mosaicism of gene mutation in type 2A, 2B and 2M VWD. Thrombosis Journal. 2016; 14:(Suppl 1):36. https://doi.org/10.1186/s12959-016-0092-2 .
    [Google الباحث العلمي]
  14. Levy G, Ginsburg D. Getting at the variable expressivity of von Willebrand disease. Thrombosis and Haemostasis. 2001; 86:(1):144–148.
    [Google الباحث العلمي]
  15. Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, et al. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus blood group O-related von Willebrand factor deficiency, and dominant type 1 VWD. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2006; 12:(3):277–295. https://doi.org/10.1177/1076029606291401 .
    [Google الباحث العلمي]
  16. Veyradier A, Jenkins CS, Fressinaud E, Meyer D. Acquired von Willebrand syndrome: From pathophysiology to management. Thrombosis and Hemostasis. 2000; 84:(2):175–182.
    [Google الباحث العلمي]
  17. Boender J, Kruip MJHA, Leebeek FWG. A diagnostic approach to mild bleeding disorders. Journal of Thrombosis and Haemostasis. 2016; 14:(8):1507–1516. https://doi.org/10.1111/jth.13368 .
    [Google الباحث العلمي]
  18. Ward SE, O’Sullivan JM, O’Donnell, JS. The relationship between ABO blood group, von Willebrand factor, and primary hemostasis. Blood. 2020; 136:(25):2864–2874. https://doi.org/10.1182/blood.2020005843 .
    [Google الباحث العلمي]
  19. James PD, Connell NT, Ameer B, Di Paola J, Eikenboom J, Giraud N, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Advances. 2021; 5:(1):280–300. https://doi.org/10.1182/bloodadvances.2020003265 .
    [Google الباحث العلمي]
  20. Doshi BS, Rogers RS, Whitworth HB, Stabnick EA, Britton J, Butler RB, et al. Utility of repeat testing in the evaluation for von Willebrand disease in pediatric patients. Journal of Thrombosis and Haemostasis. 2019; 17:(11):1838–1847. https://doi.org/10.1111/jth.14591 .
    [Google الباحث العلمي]
  21. Flood VH, Friedman KD, Gill JC, Morateck PA, Wren JS, Scott JP, et al. Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function. Journal of Thrombosis and Haemostasis. 2009; 7:(11):1832–1839. https://doi.org/10.1111/j.1538-7836.2009.03594.x .
    [Google الباحث العلمي]
  22. Boender J, Eikenboom J, van der Bom JG, Meijer K, de Meris J, Fijnvandraat K et al. Clinically relevant differences between assays for von Willebrand factor activity. Journal of Thrombosis and Haemostasis. 2018; 16:(12):2413–2424. https://doi.org/10.1111/jth.14319 .
    [Google الباحث العلمي]
  23. Favaloro EJ, Mohammed S. Laboratory testing for von Willebrand factor collagen binding (VWF:CB). Methods in Molecular Biology. 2017;1646:417–433. https://doi.org/10.1007/978-1-4939-7196-1_31 .
    [Google الباحث العلمي]
  24. Saadalla A, Seheult J, Pruthi RK, Chen D. Von Willebrand factor multimer analysis and classification: A comprehensive review and updates. Seminars in Thrombosis and Hemostasis. 2023; 49:(6):580–591. https://doi.org/10.1055/s-0042-1757183 .
    [Google الباحث العلمي]
  25. Mohammed S, Favaloro EJ. Laboratory testing for von Willebrand factor: Factor VIII binding (for 2N VWD). Methods in Molecular Biology. 2017;1646:461–472. https://doi.org/10.1007/978-1-4939-7196-1_34 .
    [Google الباحث العلمي]
/content/journals/10.5339/qjph.2024.13
Loading
/content/journals/10.5339/qjph.2024.13
Loading

جارٍ تحميل البيانات والوسائط...

  • نوع المستند: Research Article
الموضوعات الرئيسية epistaxislow von Willebrand factornosebleedpediatric and Von Willebrand disease
هذه الخانة مطلوبة
يُرجى إدخال عنوان بريد إلكتروني صالح
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error